John C.k. Milligan IV, President/Secretary at TherapeuticsMD, Inc. (TXMD), sold 250,000 shares at $5.33 ($1.3M) on 2018-10-23, disclosed to the SEC on 2018-10-25.
Open-market sale of $1.3M TXMD by President/Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.33 | 125,000 | $666K | 49.8% |
| 2 | $5.37 | 125,000 | $671K | 50.2% |
| Total | $5.35 avg | 250,000 | $1.3M | 100% |
| Filing → |
| TXMD | BUY | 2019-08-19 | $29K | — | Filing → |
| TXMD | BUY | 2019-08-14 | $47K | — | Filing → |
| TXMD | SELL | 2018-12-19 | $1.4M | — | Filing → |